+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

STD Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments and Services, Consumables), Application (HIV Testing, HSV Testing, Chlamydia Testing), Technology, Location of Testing, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 156 Pages
  • January 2024
  • Region: Global
  • Grand View Research
  • ID: 5846796
Description Jump to:
The global STD diagnostics market is expected to reach USD 16.36 billion by 2030, expanding at a CAGR of 7.18% from 2024 to 2030. The increasing disease burden of Sexually Transmitted Disease (STD) and efforts by government & non-profit organizations to increase awareness and encourage regular screenings among the younger population are the key factors augmenting the market growth. According to WHO data, around 374 million new cases of syphilis, gonorrhea, chlamydia, and trichomoniasis are recorded every year globally.

Development and commercialization of advanced products, such as next-generation HIV testing kits and multiplex PCR products, enable physicians to timely diagnose & distinguish a range of STIs and provide appropriate treatment. Seegene, Inc., a South Korea-based diagnostic company, provides a wide portfolio of Allplex, Anyplex, and Seeplex products that detect various causative agents. For instance, Allplex STI/BV Panel Assay can distinguish 28 causative agents in a single test. In April 2022, Seegene, Inc. announced the development of Allplex HPV HR Detection.

Allplex HPV HR Detection is the world’s first commercialized ‘3 Ct’ PCR assay. Seegene is focusing to apply this technology to its entire product chain, including STI, Urinary Tract Infection (UTI), and Respiratory Virus (RV) assays. This strategic technological advancement is expected to provide an additional advantage to the company that can help increase its share in the Sexually Transmitted Disease (STD) diagnostics industry.

The HIV National Strategic Plan is a roadmap for eliminating the human immunodeficiency virus pandemic in the U.S. by 2030. The HIV Plan, which will run from 2021 to 2025, is the country's third five-year national HIV plan in a row, with a 10-year goal of halving new human immunodeficiency virus infections by 90% by 2030. Furthermore, the Viral Hepatitis National Strategic Plan focuses on hepatitis B and C, which are sexually transmitted. In January 2021, the US Department of Health and Human Services (HHS) released a nationwide strategy to address the preventable, substantial public health threats posed by viral hepatitis in the United States. The government's beneficial actions create a favorable atmosphere for the expansion of the STD diagnostics industry.

Companies are engaging in strategic initiatives that aid in the development of new products, and regulatory approvals as well as enhance their STD diagnostics product portfolio. For instance, in August 2020, DiaSorin, Inc. received 510 (k) approval from U.S. FDA for introducing LIAISON XL MUREX anti-HBe. It is used for the diagnosis of HBV infection. This immunoassay product works on the principle of chemiluminescence.

STD Diagnostics Market Report Highlights

  • In 2023, the consumables segment accounted for the largest market share and is anticipated to maintain its position over the forecast period owing to high testing rates for the diagnosis of STDs and the commercialization of several assays
  • Based on technology, the molecular diagnostics segment is estimated to grow at the fastest CAGR during the forecast period owing to the increasing use of high-throughput PCR technology and the recommendation of NAAT tests for HIV testing. The development of multiplex PCR tests for the simultaneous detection of multiple pathogens is also expected to contribute to the STD diagnostics industry's growth
  • Based on application, the HIV testing segment is expected to dominate the STD diagnostics industry in 2023, due to factors such as the high incidence rate of the disease, increasing product approvals for molecular tests, and favorable government initiatives
  • Asia-Pacific region is anticipated to experience the fastest growth over the forecast period due to an increase in testing rates for STDS, a rise in disposable income, and high disease prevalence of STD in developing countries

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List Of Secondary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Product And Application Snapshot
2.3 Technology And Location Of Testing Snapshot
2.4 Competitive Snapshot
Chapter 3 STD Diagnostics Market Variables, Trends, And Scope
3.1 Penetration And Growth Prospect Mapping
3.2 User Perspective Analysis
3.3 Regulatory And Reimbursement Framework
3.4 Market Driver Analysis
3.4.1 Growing Global Disease Burden Of STDs
3.4.2 Technological Advancements In STD Diagnostics
3.4.3 Government Initiatives Encouraging Early Diagnosis And Treatment
3.5 Market Restraint Analysis
3.5.1 Vaccination Coverage For STDs
3.6 Covid-19 Impact Analysis
3.7 Swot Analysis, by Factor (Political & Legal, Economic, And Technological)
3.8 Industry Analysis - Porter’s
Chapter 4 STD Diagnostics Market: Segment Analysis, by Product, 2018-2030 (USD Million)
4.1 STD Diagnostics Market: Product Movement Analysis
4.2 Instruments And Services
4.2.1 Instruments And Services Market, 2018-2030 (USD Million)
4.3 Consumables
4.3.1 Consumables Market, 2018-2030 (USD Million)
4.4 Software
4.4.1 Software Market, 2018-2030 (USD Million)
Chapter 5 STD Diagnostics Market: Segment Analysis, by Application, 2018-2030 (USD Million)
5.1 STD Diagnostics Market: Application Movement Analysis
5.2 Ct/Ng Testing
5.2.1 Ct/Ng Testing Market, 2018-2030 (USD Million)
5.3 Syphilis Testing
5.3.1 Syphilis Testing Market, 2018-2030 (USD Million)
5.3.2 Syphilis Pcr Testing Market, 2018-2030 (USD Million)
5.3.3 Syphilis Non-Pcr Testing Market, 2018-2030 (USD Million)
5.4 Hsv Testing
5.4.1 Hsv Testing Market, 2018-2030 (USD Million)
5.4.2 Herpes Simplex Virus Pcr Testing Market, 2018-2030 (USD Million)
5.4.3 Herpes Simplex Virus Non-Pcr Testing Market, 2018-2030 (USD Million)
5.5 Hpv Testing
5.5.1 Hpv Testing Market, 2018-2030 (USD Million)
5.6 Hiv Testing
5.6.1 Human Immunodeficiency Virus Testing Market, 2018-2030 (USD Million)
5.7 Ureaplasma & Mycoplasma Testing
5.7.1 Ureaplasma & Mycoplasma Testing Market, 2018-2030 (USD Million)
5.8 Trichomonas Testing
5.8.1 Trichomonas Testing Market, 2018-2030 (USD Million)
5.9 Vzv Testing
5.9.1 Vzv Testing Market, 2018-2030 (USD Million)
5.9.2 Vzv Pcr Testing Market, 2018-2030 (USD Million)
5.9.3 Vzv Non-Pcr Testing Market, 2018-2030 (USD Million)
5.10 Gonorrheatesting
5.10.1 Gonorrhea Testing Market, 2018-2030 (USD Million)
5.11 Other Testing
5.11.1 Other Testing Market, 2018-2030 (USD Million)
Chapter 6 STD Diagnostics Market: Segment Analysis, by Technology, 2018-2030 (USD Million)
6.1 STD Diagnostics Market: Technology Movement Analysis
6.2 Molecular Diagnostics
6.2.1 Molecular Diagnostics Market, 2018-2030 (USD Million)
6.3 Immunoassay
6.3.1 Immunoassay Market, 2018-2030 (USD Million)
6.4 Others
6.4.1 Others Market, 2018-2030 (USD Million)
Chapter 7 STD Diagnostics Market: Segment Analysis, by Location Of Testing, 2018-2030 (USD Million)
7.1 STD Diagnostics Market: Location Of Testing Movement Analysis
7.2 Laboratory Testing
7.2.1 Laboratory Testing Market, 2018-2030 (USD Million)
7.2.2 Commercial/Private Labs
7.2.2.1 Commercial/Private Labs Market, 2018-2030 (USD Million)
7.2.3 Public Health Labs
7.2.3.1 Public Health Labs Market, 2018-2030 (USD Million)
7.3 Point Of Care Testing
7.3.1 Point Of Care Testing Market, 2018-2030 (USD Million)
Chapter 8 STD Diagnostics Market: Segment Analysis, by Region, 2018-2030 (USD Million)
8.1 STD Diagnostics Market: Regional Outlook
8.2 North America
8.2.1 North America STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.2.2 U.S.
8.2.2.1 Key Country Dynamics
8.2.2.2 U.S. STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.2.2.3 Target Disease: Cancer Incidence
8.2.2.4 Market And Competitive Scenario
8.2.2.5 Regulatory Framework
8.2.2.6 Reimbursement Scenario
8.2.3 Canada
8.2.3.1 Key Country Dynamics
8.2.3.2 Canada STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.2.3.3 Target Disease: Cancer Incidence
8.2.3.4 Market And Competitive Scenario
8.2.3.5 Regulatory Framework
8.2.3.6 Reimbursement Scenario
8.3 Europe
8.3.1 Europe STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.2 UK
8.3.2.1 Key Country Dynamics
8.3.2.2 Uk STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.2.3 Target Disease Prevalence
8.3.2.4 Market And Competitive Scenario
8.3.2.5 Regulatory Framework
8.3.2.6 Reimbursement Scenario
8.3.3 Germany
8.3.3.1 Key Country Dynamics
8.3.3.2 Germany STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.3.3 Target Disease Prevalence
8.3.3.4 Market And Competitive Scenario
8.3.3.5 Regulatory Framework
8.3.3.6 Reimbursement Scenario
8.3.4 France
8.3.4.1 Key Country Dynamics
8.3.4.2 France STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.4.3 Target Disease Prevalence
8.3.4.4 Market And Competitive Scenario
8.3.4.5 Regulatory Framework
8.3.4.6 Reimbursement Scenario
8.3.5 Spain
8.3.5.1 Key Country Dynamics
8.3.5.2 Spain STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.5.3 Target Disease Prevalence
8.3.5.4 Market And Competitive Scenario
8.3.5.5 Regulatory Framework
8.3.5.6 Reimbursement Scenario
8.3.6 Italy
8.3.6.1 Key Country Dynamics
8.3.6.2 Italy STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.6.3 Target Disease Prevalence
8.3.6.4 Market And Competitive Scenario
8.3.6.5 Regulatory Framework
8.3.6.6 Reimbursement Scenario
8.3.7 Denmark
8.3.7.1 Key Country Dynamics
8.3.7.2 Denmark STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.7.3 Target Disease Prevalence
8.3.7.4 Market And Competitive Scenario
8.3.7.5 Regulatory Framework
8.3.7.6 Reimbursement Scenario
8.3.8 Sweden
8.3.8.1 Key Country Dynamics
8.3.8.2 Sweden STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.8.3 Target Disease Prevalence
8.3.8.4 Market And Competitive Scenario
8.3.8.5 Regulatory Framework
8.3.8.6 Reimbursement Scenario
8.3.9 Norway
8.3.9.1 Key Country Dynamics
8.3.9.2 Norway STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.9.3 Target Disease Prevalence
8.3.9.4 Market And Competitive Scenario
8.3.9.5 Regulatory Framework
8.3.9.6 Reimbursement Scenario
8.3.10 Rest Of Europe STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4 Asia-Pacific
8.4.1 Asia-Pacific STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.2 Japan
8.4.2.1 Key Country Dynamics
8.4.2.2 Japan STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.2.3 Target Disease Prevalence
8.4.2.4 Market And Competitive Scenario
8.4.2.5 Regulatory Framework
8.4.2.6 Reimbursement Scenario
8.4.3 China
8.4.3.1 Key Country Dynamics
8.4.3.2 China STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.3.3 Target Disease Prevalence
8.4.3.4 Market And Competitive Scenario
8.4.3.5 Regulatory Framework
8.4.3.6 Reimbursement Scenario
8.4.4 India
8.4.4.1 Key Country Dynamics
8.4.4.2 India STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.4.3 Target Disease Prevalence
8.4.4.4 Market And Competitive Scenario
8.4.4.5 Regulatory Framework
8.4.4.6 Reimbursement Scenario
8.4.5 Australia
8.4.5.1 Key Country Dynamics
8.4.5.2 Australia STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.5.3 Target Disease Prevalence
8.4.5.4 Market And Competitive Scenario
8.4.5.5 Regulatory Framework
8.4.5.6 Reimbursement Scenario
8.4.6 Thailand
8.4.6.1 Key Country Dynamics
8.4.6.2 Thailand STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.6.3 Target Disease Prevalence
8.4.6.4 Market And Competitive Scenario
8.4.6.5 Regulatory Framework
8.4.6.6 Reimbursement Scenario
8.4.7 South Korea
8.4.7.1 Key Country Dynamics
8.4.7.2 South Korea STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.7.3 Target Disease Prevalence
8.4.7.4 Market And Competitive Scenario
8.4.7.5 Regulatory Framework
8.4.7.6 Reimbursement Scenario
8.4.8 Rest Of Asia-Pacific STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.5 Latin America
8.5.1 Latin America STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Key Country Dynamics
8.5.2.2 Brazil STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.5.2.3 Target Disease Prevalence
8.5.2.4 Competitive Scenario
8.5.2.5 Regulatory Framework
8.5.2.6 Reimbursement Scenario
8.5.3 Mexico
8.5.3.1 Key Country Dynamics
8.5.3.2 Mexico STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.5.3.3 Target Disease Prevalence
8.5.3.4 Competitive Scenario
8.5.3.5 Regulatory Framework
8.5.3.6 Reimbursement Scenario
8.5.4 Argentina
8.5.4.1 Key Country Dynamics
8.5.4.2 Argentina STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.5.4.3 Target Disease Prevalence
8.5.4.4 Competitive Scenario
8.5.4.5 Regulatory Framework
8.5.4.6 Reimbursement Scenario
8.5.5 Rest Of Latin America STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.6 Mea
8.6.1 Mea STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.6.2 South Africa
8.6.2.1 Key Country Dynamics
8.6.2.2 South Africa STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.6.2.3 Target Disease Prevalence
8.6.2.4 Competitive Scenario
8.6.2.5 Regulatory Framework
8.6.2.6 Reimbursement Scenario
8.6.3 Saudi Arabia
8.6.3.1 Key Country Dynamics
8.6.3.2 Saudi Arabia STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.6.3.3 Target Disease Prevalence
8.6.3.4 Competitive Scenario
8.6.3.5 Regulatory Framework
8.6.3.6 Reimbursement Scenario
8.6.4 UAE
8.6.4.1 Key Country Dynamics
8.6.4.2 Uae STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.6.4.3 Target Disease Prevalence
8.6.4.4 Competitive Scenario
8.6.4.5 Regulatory Framework
8.6.4.6 Reimbursement Scenario
8.6.5 Kuwait
8.6.5.1 Key Country Dynamics
8.6.5.2 Kuwait STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
8.6.5.3 Target Disease Prevalence
8.6.5.4 Competitive Scenario
8.6.5.5 Regulatory Framework
8.6.5.6 Reimbursement Scenario
8.6.6 Rest Of Mea STD Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 9 STD Diagnostics Market: Competitive Analysis
9.1 Recent Developments And Impact Analysis, by Key Market Participants
9.1.1 New Product Launches
9.1.2 Mergers And Acquisitions
9.1.3 Partnerships And Strategic Collaboration
9.1.4 Conferences And Campaigns
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.2.3 Heat Map Analysis
9.3 Vendor Landscape
9.3.1 List Of Key Distributors And Channel Partners
9.3.2 Key Customers
9.4 Key Company Market Share Analysis, 2022
9.5 Public Companies
9.5.1 Company Market Position Analysis
9.5.2 Competitive Dashboard Analysis
9.5.2.1 Market Differentiators
9.6 Private Companies
9.6.1 List Of Key Emerging Companies
9.6.2 Regional Network Map
9.7 Company Profiles
9.7.1 BD
9.7.1.1 Company Overview
9.7.1.2 Financial Performance
9.7.1.3 Product benchmarking
9.7.1.4 Strategic initiatives
9.7.2 F. HOFFMANN-LA ROCHE LTD.
9.7.2.1 Company overview
9.7.2.2 Financial Performance
9.7.2.3 Product benchmarking
9.7.2.4 Strategic initiatives
9.7.3 HOLOGIC INC. (GEN PROBE)
9.7.3.1 Company Overview
9.7.3.2 Financial Performance
9.7.3.3 Product Benchmarking
9.7.3.4 Strategic Initiatives
9.7.4 ABBOTT
9.7.4.1 Company Overview
9.7.4.2 Financial Performance
9.7.4.3 Product Benchmarking
9.7.4.4 Strategic Initiatives
9.7.5 CEPHEID (DANAHER)
9.7.5.1 Company Overview
9.7.5.2 Financial Performance
9.7.5.3 Product Benchmarking
9.7.5.4 Strategic Initiatives
9.7.6 QIAGEN
9.7.6.1 Company Overview
9.7.6.2 Financial Performance
9.7.6.3 Product Benchmarking
9.7.6.4 Strategic Initiatives
9.7.7 ORASURE TECHNOLOGIES, INC
9.7.7.1 Company Overview
9.7.7.2 Financial Performance
9.7.7.3 Product Benchmarking
9.7.7.4 Strategic Initiatives
9.7.8 BIO-RAD LABORATORIES, INC.
9.7.8.1 Company Overview
9.7.8.2 Financial Performance
9.7.8.3 Product Benchmarking
9.7.8.4 Strategic Initiatives
9.7.9 BIOMÉRIEUX SA
9.7.9.1 Company overview
9.7.9.2 Financial Performance
9.7.9.3 Product benchmarking
9.7.9.4 Strategic initiatives
9.7.10 THERMO FISHER SCIENTIFIC, INC.
9.7.10.1 Company overview
9.7.10.2 Financial performance
9.7.10.3 Product benchmarking
9.7.10.4 Strategic initiatives
9.7.11 SEEGENE INC.
9.7.11.1 Company overview
9.7.11.2 Financial performance
9.7.11.3 Product benchmarking
9.7.11.4 Strategic initiatives
9.7.12 DIASORIN S.P.A
9.7.12.1 Company overview
9.7.12.2 Financial performance
9.7.12.3 Product benchmarking
9.7.12.4 Strategic initiatives
Chapter 10 Conclusion
List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 List of key distributors
Table 4 List of other companies
Table 5 List of key emerging companies/technology disruptors/innovators
Table 6 Global STD Diagnostics Market, By Region, 2018-2030 (USD Million)
Table 7 Global STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 8 Global STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 9 Global STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 10 Global STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 11 North America STD Diagnostics Market, By Country, 2018-2030 (USD Million)
Table 12 North America STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 13 North America STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 14 North America STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 15 North America STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 16 U.S. STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 17 U.S. STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 18 U.S. STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 19 U.S. STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 20 Canada STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 21 Canada STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 22 Canada STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 23 Canada STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 24 Europe STD Diagnostics Market, By Country, 2018-2030 (USD Million)
Table 25 Europe STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 26 Europe STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 27 Europe STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 28 Europe STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 29 UK STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 30 UK STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 31 UK STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 32 UK STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 33 Germany STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 34 Germany STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 35 Germany STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 36 Germany STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 37 France STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 38 France STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 39 France STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 40 France STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 41 Spain STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 42 Spain STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 43 Spain STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 44 Spain STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 45 Italy STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 46 Italy STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 47 Italy STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 48 Italy STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 49 Denmark STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 50 Denmark STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 51 Denmark STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 52 Denmark STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 53 Sweden STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 54 Sweden STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 55 Sweden STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 56 Sweden STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 57 Norway STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 58 Norway STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 59 Norway STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 60 Norway STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 61 Asia-Pacific STD Diagnostics Market, By Country, 2018-2030 (USD Million)
Table 62 Asia-Pacific STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 63 Asia-Pacific STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 64 Asia-Pacific STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 65 Asia-Pacific STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 66 Japan STD Diagnostics Market, By Product Type, 2018-2030 (USD Million)
Table 67 Japan STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 68 Japan STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 69 Japan STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 70 China STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 71 China STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 72 China STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 73 China STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 74 India STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 75 India STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 76 India STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 77 India STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 78 Australia STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 79 Australia STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 80 Australia STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 81 Australia STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 82 South Korea STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 83 South Korea STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 84 South Korea STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 85 South Korea STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 86 Thailand STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 87 Thailand STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 88 Thailand STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 89 Thailand STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 90 Latin America STD Diagnostics Market, By Country, 2018-2030 (USD Million)
Table 91 Latin America STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 92 Latin America STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 93 Latin America STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 94 Latin America STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 95 Brazil STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 96 Brazil STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 97 Brazil STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 98 Brazil STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 99 Mexico STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 100 Mexico STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 101 Mexico STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 102 Mexico STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 103 Argentina STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 104 Argentina STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 105 Argentina STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 106 Argentina STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 107 MEA STD Diagnostics Market, By Country, 2018-2030 (USD Million)
Table 108 MEA STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 109 MEA STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 110 MEA STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 111 MEA STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 112 South Africa STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 113 South Africa STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 114 South Africa STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 115 South Africa STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 116 Saudi Arabia STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 117 Saudi Arabia STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 118 Saudi Arabia STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 119 Saudi Arabia STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 120 UAE STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 121 UAE STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 122 UAE STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 123 UAE STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
Table 124 Kuwait STD Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 125 Kuwait STD Diagnostics Market, By Technology, 2018-2030 (USD Million)
Table 126 Kuwait STD Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 127 Kuwait STD Diagnostics Market, By Location of Testing, 2018-2030 (USD Million)
List of Figures
Fig. 1 STD Diagnostics Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2023)
Fig. 10 Penetration and growth prospect mapping
Fig. 11 User perspective analysis
Fig. 12 STD Diagnostics Market driver impact
Fig. 13 Prevalence of STIs by WHO regions (in 2023)
Fig. 14 STD Diagnostics Market restraint impact
Fig. 15 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
Fig. 16 Porter’s Five Forces Analysis
Fig. 17 STD diagnostics product outlook: Key takeaways
Fig. 18 STD Diagnostics Market: Product movement analysis
Fig. 19 Instruments and Services market, 2018-2030 (USD Million)
Fig. 20 Consumables market, 2018-2030 (USD Million)
Fig. 21 Software market, 2018-2030 (USD Million)
Fig. 22 STD diagnostics application outlook: Key takeaways
Fig. 23 STD Diagnostics Market: Application movement analysis
Fig. 24 CT/NG testing market, 2018-2030 (USD Million)
Fig. 25 Prevalence (%) of syphilis by WHO regions
Fig. 26 Syphilis testing market, 2018-2030 (USD Million)
Fig. 27 Syphilis PCR testing market, 2018-2030 (USD Million)
Fig. 28 Syphilis non-PCR testing market, 2018-2030 (USD Million)
Fig. 29 HSV testing market, 2018-2030 (USD Million)
Fig. 30 Herpes Simplex Virus PCR testing market, 2018-2030 (USD Million)
Fig. 31 Herpes Simplex Virus non-PCR testing market, 2018-2030 (USD Million)
Fig. 32 HPV testing market, 2018-2030 (USD Million)
Fig. 33 Prevalence (%) of HIV by WHO regions
Fig. 34 HIV testing market, 2018-2030 (USD Million)
Fig. 35 Ureaplasma & mycoplasma testing market, 2018-2030 (USD Million)
Fig. 36 Trichomonas testing market, 2018-2030 (USD Million)
Fig. 37 VZV testing market, 2018-2030 (USD Million)
Fig. 38 VZV PCR testing market, 2018-2030 (USD Million)
Fig. 39 VZV non-PCR testing market, 2018-2030 (USD Million)
Fig. 40 Other testing market, 2018-2030 (USD Million)
Fig. 41 STD diagnostics technology outlook: Key takeaways
Fig. 42 STD Diagnostics Market: Technology movement analysis
Fig. 43 Molecular Diagnostics market, 2018-2030 (USD Million)
Fig. 44 Immunoassay market, 2018-2030 (USD Million)
Fig. 45 Others market, 2018-2030 (USD Million)
Fig. 46 STD diagnostics location of testing outlook: Key takeaways
Fig. 47 STD Diagnostics Market: Location of testing movement analysis
Fig. 48 Laboratory testing market, 2018-2030 (USD Million)
Fig. 49 Commercial/private labs market, 2018-2030 (USD Million)
Fig. 50 Public health labs market, 2018-2030 (USD Million)
Fig. 51 Point of care testing market, 2018-2030 (USD Million)
Fig. 52 Regional outlook, 2023 & 2030
Fig. 53 Regional marketplace: Key takeaways
Fig. 54 North America SWOT
Fig. 55 North America STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 56 U.S. Country Dynamics
Fig. 57 U.S. Target Disease Prevalence
Fig. 58 U.S. STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 59 Canada Country Dynamics
Fig. 60 Canada Target Disease Prevalence
Fig. 61 Canada STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 62 Europe SWOT
Fig. 63 Europe STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 64 UK Country Dynamics
Fig. 65 UK Target Disease Prevalence
Fig. 66 UK STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 67 Germany Country Dynamics
Fig. 68 GermanyTarget Disease Prevalence
Fig. 69 Germany STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 70 France Country Dynamics
Fig. 71 France Target Disease Prevalence
Fig. 72 France STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 73 Spain Country Dynamics
Fig. 74 Spain Target Disease Prevalence
Fig. 75 Spain STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 76 Italy Country Dynamics
Fig. 77 Italy Target Disease Prevalence
Fig. 78 Italy STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 79 Denmark Country Dynamics
Fig. 80 Denmark Target Disease Prevalence
Fig. 81 Denmark STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 82 Sweden Country Dynamics
Fig. 83 Sweden Target Disease Prevalence
Fig. 84 Sweden STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 85 Denmark Country Dynamics
Fig. 86 Denmark Target Disease Prevalence
Fig. 87 Denmark STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 88 Asia-Pacific SWOT
Fig. 89 Asia-Pacific STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 90 Japan Country Dynamics
Fig. 91 Japan Target Disease Prevalence
Fig. 92 Japan STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 93 China Country Dynamics
Fig. 94 China Target Disease Prevalence
Fig. 95 China STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 96 India Country Dynamics
Fig. 97 India Target Disease Prevalence
Fig. 98 India STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 99 Australia Country Dynamics
Fig. 100 Australia Target Disease Prevalence
Fig. 101 Australia STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 102 South Korea Country Dynamics
Fig. 103 South Korea Target Disease Prevalence
Fig. 104 South Korea STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 105 Thailand Country Dynamics
Fig. 106 Thailand Target Disease Prevalence
Fig. 107 Thailand STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 108 Latin America SWOT
Fig. 109 Latin America STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 110 Brazil Country Dynamics
Fig. 111 Brazil Target Disease Prevalence
Fig. 112 Brazil STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 113 Mexico Country Dynamics
Fig. 114 Mexico Target Disease Prevalence
Fig. 115 Mexico STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 116 Argentina Country Dynamics
Fig. 117 Argentina Target Disease Prevalence
Fig. 118 Argentina STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 119 Middle East & Africa SWOT
Fig. 120 Middle East & Africa STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 121 South Africa Country Dynamics
Fig. 122 South Africa Target Disease Prevalence
Fig. 123 South Africa STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 124 Saudi Arabia Country Dynamics
Fig. 125 Saudi Arabia Target Disease Prevalence
Fig. 126 Saudi Arabia STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 127 UAE Country Dynamics
Fig. 128 UAE Target Disease Prevalence
Fig. 129 UAE STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 130 Kuwait Country Dynamics
Fig. 131 Kuwait Target Disease Prevalence
Fig. 132 Kuwait STD Diagnostics Market, 2018-2030 (USD Million)
Fig. 133 Heat map analysis
Fig. 134 Company market share analysis (2023)
Fig. 135 Company market position analysis (2023)
Fig. 136 Company market position analysis (2023)
Fig. 137 Market differentiators
Fig. 138 Regional Network Map

Companies Mentioned

  • BD
  • F. Hoffmann-la Roche Ltd.
  • Hologic Inc. (Gen Probe)
  • Abbott
  • Cepheid (Danaher)
  • Qiagen
  • Orasure Technologies, Inc
  • Bio-rad Laboratories, Inc.
  • Biomérieux Sa
  • Thermo Fisher Scientific, Inc.
  • Seegene Inc.
  • Diasorin S.P.A

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages156
PublishedJanuary 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 10.06 Billion
Forecasted Market Value ( USD ) by 2030 $ 16.36 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

STD Testing Market by Type, Product Type, Test Settings, Indication, End-user - Global Forecast 2025-2030 - Product Image

STD Testing Market by Type, Product Type, Test Settings, Indication, End-user - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Sexually Transmitted Diseases Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Sexually Transmitted Diseases Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
STD Testing Device Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

STD Testing Device Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
STD Diagnostics Global Market Report 2024 - Product Image

STD Diagnostics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Sexually Transmitted Disease Diagnostics Market by Disease Type, Diagnostic methods, Device Type, End-Users - Global Forecast 2025-2030 - Product Image

Sexually Transmitted Disease Diagnostics Market by Disease Type, Diagnostic methods, Device Type, End-Users - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.